VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Disappointing call today

<< Previous

Bullboard Posts

Next >>

Comment by JohnPhilipon Apr 04, 2024 5:10pm

104 Views

Post# 35971413

RE:RE:RE:Disappointing call today

My concerns about Ascend promoting VPT on the Ascend website was mentioned. I liked the fact that charity organizations could help with fund raising for hospitals to purchase VPT systems. I also felt like Hugh was in charge and his goals were realistic.

I also liked the fact that Hugh purchased shares on March 28.

No mention of hiring a new CEO in the near future. I am assuming the new CEO will be somone hand picked with goals that align with the current plan.

Next news may be a financing deal in place.

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Nov. 14, 2024